miR-21 also confers Cisplatin resistant in gastric cancer cells, which was coincident with previous studies, for example, exosomal transfer of tumour-associated macrophage-derived miR-21 confers Cisplatin resistance in gastric cancer by regulating PI3K/AKT pathway31 and PTEN.32 The gene discussed is AKT1; the disease is gastric cancer.